Curcumin enhances non-inflammatory phagocytic activity of RAW264.7 cells

Biochemical and Biophysical Research Communications

Volumn 379, Issue 2, 2009, Pages 632-636

  Bisht, Kavita ^a   Choi, Woo H ^a   Park, Shin Y ^a   Chung, Moon K ^a   Koh, Woo S ^a  

^a Korea Institute of Toxicology   (South Korea)

Author keywords

CD14; Curcumin; Macrophage; Phagocytosis

Indexed keywords

CD14 ANTIGEN; CD40 ANTIGEN; CURCUMIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION REGULATION; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYNTHESIS; UPREGULATION;

ANIMALS; ANTIGENS, CD14; ANTIGENS, CD40; CELL CYCLE; CURCUMIN; INFLAMMATION; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; PHAGOCYTOSIS; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE;

EID: 58149514052     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.12.135     Document Type: Article

References (37)

1. Ammon H.P., and Wahl M.A. Pharmacology of Curcuma longa. Planta Med. 57 (1991) 1-7
2. Huang H.C., Jan T.R., and Yeh S.F. Inhibitory effect of curcumin, an anti-inflammatory agent, on vascular smooth muscle cell proliferation. Eur. J. Pharmacol. 221 (1992) 381-384
3. Joe B., and Lokesh B.R. Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim. Biophys. Acta 1224 (1994) 255-263
4. Ruby A.J., Kuttan G., Babu K.D., Rajasekharan K.N., and Kuttan R. Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett. 94 (1995) 79-83
5. Rao C.V., Rivenson A., Simi B., and Reddy B.S. Chemoprevention of colon carcinogenesis by dietary curcumin. A naturally occurring plant phenolic compound. Cancer Res. 55 (1995) 259-266
6. Gao X., Kuo J., Jiang H., Deeb D., Liu Y., Divine G., Chapman R.A., Dulchavsky S.A., and Gautam S.C. Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro. Biochem. Pharmacol. 68 (2004) 51-61
7. Ranjan D., Chen C., Johnston T.D., Jeon H., and Nagabhushan M. Curcumin inhibits mitogen stimulated lymphocyte proliferation, NFkappaB activation, and IL-2 signaling. J. Surg. Res. 121 (2004) 171-177
8. Yadav V.S., Mishra K.P., Singh D.P., Mehrotra S., and Singh V.K. Immunomodulatory effects of curcumin. Immunopharmacol. Immunotoxicol. 27 (2005) 485-497
9. Chan M.M. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem. Pharmacol. 49 (1995) 1551-1556
10. Abe Y., Hashimoto S., and Horie T. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol. Res. 39 (1999) 41-47
11. Moon D.O., Jin C.Y., Lee J.D., Choi Y.H., Ahn S.C., Lee C.M., Jeong S.C., Park Y.M., and Kim G.Y. Curcumin decreases binding of Shiga-like toxin-1B on human intestinal epithelial cell line HT29 stimulated with TNF-alpha and IL-1beta: suppression of p38, JNK and NF-kappaB p65 as potential targets. Biol. Pharm. Bull. 29 (2006) 1470-1475
12. Brouet I., and Ohshima H. Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem. Biophys. Res. Commun. 206 (1995) 533-540
13. Bhaumik S., Jyothi M.D., and Khar A. Differential modulation of nitric oxide production by curcumin in host macrophages and NK cells. FEBS Lett. 483 (2000) 78-82
14. Shirley S.A., Montpetit A.J., Lockey R.F., and Mohapatra S.S. Curcumin prevents human dendritic cell response to immune stimulants. Biochem. Biophys. Res. Commun. 374 (2008) 431-436
15. Kim G.Y., Kim K.H., Lee S.H., Yoon M.S., Lee H.J., Moon D.O., Lee C.M., Ahn S.C., Park Y.C., and Park Y.M. Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets. J. Immunol. 174 (2005) 8116-8124
16. Sharma S., Chopra K., Kulkarni S.K., and Agrewala J.N. Resveratrol and curcumin suppress immune response through CD28/CTLA-4 and CD80 co-stimulatory pathway. Clin. Exp. Immunol. 147 (2007) 155-163
17. Gordon S. The role of the macrophage in immune regulation. Res. Immunol. 149 (1998) 685-688
18. Morrissette N., Gold E., and Aderem A. The macrophage-a cell for all seasons. Trends Cell Biol. 9 (1999) 199-201
19. Evans R., Kamdar S.J., and Duffy T.M. Tumor-derived products induce Il-1 a, Il-1 b, Tnf a, and Il-6 gene expression in murine macrophages: distinctions between tumor- and bacterial endotoxin-induced gene expression. J. Leukoc. Biol. 49 (1991) 474-482
20. Nathan C. Inducible nitric oxide synthase: what difference does it make?. J. Clin. Invest. 100 (1997) 2417-2423
21. Bogdan C. Nitric oxide and the immune response. Nat. Immunol. 2 (2001) 907-916
22. Barbour S.E., Wong C., Rabah D., Kapur A., and Carter A.D. Mature macrophage cell lines exhibit variable responses to LPS. Mol. Immunol. 35 (1998) 977-987
23. Kim J.K., Oh S.M., Kwon H.S., Oh Y.S., Lim S.S., and Shin H.K. Anti-inflammatory effect of roasted licorice extracts on lipopolysaccharide-induced inflammatory responses in murine macrophages. Biochem. Biophys. Res. Commun. 345 (2006) 1215-1223
24. Grewal I.S., and Flavell R.A. The role of CD40 ligand in costimulation and T-cell activation. Immunol. Rev. 153 (1996) 85-106
25. Hathcock K.S., Laszlo G., Pucillo C., Linsley P., and Hodes R.J. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. Exp. Med. 180 (1994) 631-640
26. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., and Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101 (1998) 890-898
27. Voll R.E., Herrmann M., Roth E.A., Stach C., Kalden J.R., and Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature 390 (1997) 350-351
28. Devitt A., Moffatt O.D., Raykundalia C., Capra J.D., Simmons D.L., and Gregory C.D. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 392 (1998) 505-509
29. Heidenreich S. Monocyte CD14: a multifunctional receptor engaged in apoptosis from both sides. J. Leukoc. Biol. 65 (1999) 737-743
30. Savill J., and Fadok V. Corpse clearance defines the meaning of cell death. Nature 407 (2000) 784-788
31. Fadok V.A., Bratton D.L., Rose D.M., Pearson A., Ezekewitz R.A., and Henson P.M. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405 (2000) 85-90
32. Hanayama R., Tanaka M., Miwa K., Shinohara A., Iwamatsu A., and Nagata S. Identification of a factor that links apoptotic cells to phagocytes. Nature 417 (2002) 182-187
33. Scott R.S., McMahon E.J., Pop S.M., Reap E.A., Caricchio R., Cohen P.L., Earp H.S., and Matsushima G.K. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411 (2001) 207-211
34. Park S.Y., Jung M.Y., Kim H.J., Lee S.J., Kim S.Y., Lee B.H., Kwon T.H., Park R.W., and Kim I.S. Rapid cell corpse clearance by stabilin-2. A membrane phosphatidylserine receptor. Cell Death Differ 15 (2008) 192-201
35. Lingnau M., Hoflich C., Volk H.D., Sabat R., and Docke W.D. Interleukin-10 enhances the CD14-dependent phagocytosis of bacteria and apoptotic cells by human monocytes. Hum. Immunol. 68 (2007) 730-738
36. Skrzeczynska-Moncznik J., Bzowska M., Loseke S., Grage-Griebenow E., Zembala M., and Pryjma J. Peripheral blood CD14high CD16+ monocytes are main producers of IL-10. Scand. J. Immunol. 67 (2008) 152-159
37. Varalakshmi C., Ali A.M., Pardhasaradhi B.V., Srivastava R.M., Singh S., and Khar A. Immunomodulatory effects of curcumin: in-vivo. Int. Immunopharmacol. 8 (2008) 688-700